Self-association properties of monomeric insulin analogs under formulation conditions von RICHARDS, J. P, STICKELMEYER, M. P, FLORA, D. B, CHANCE, R. E, FRANK, B. H, DEFELIPPIS, M. R

Volltext

Stability of U-10 and U-50 dilutions of insulin lispro von Stickelmeyer, M P, Graf, C J, Frank, B H, Ballard, R L, Storms, S M

Volltext

Preparation of a microcrystalline suspension formulation of Lys(B28)Pro(B29)-human insulin with ultralente properties von Richards, J P, Stickelmeyer, M P, Frank, B H, Pye, S, Barbeau, M, Radziuk, J, Smith, G D, DeFelippis, M R

Volltext

Injection-related adverse events observed with olanzapine long-acting injection von Gulliver, A, McDonnell, D P, Sorsaburu, S, Brunner, E, Detke, H C, Andersen, S W, Bergstrom, R F, Mitchell, M, Ogle, K, Stickelmeyer, M P, Corya, S A

Volltext

Preparation of a microcrystalline suspension formulation of LysB28ProB29‐human insulin with ultralente properties von Richards, Jane P., Stickelmeyer, Mary P., Frank, Bruce H., Pye, Susan, Barbeau, Michelle, Radziuk, Jerry, Smith, G.David, DeFelippis, Michael R.

Volltext